Background
The opioid epidemic in the U.S. contributes to increased morbidity and mortality from drug overdoses, but barriers to traditional opioid use disorder (OUD) treatment limit access to care. During the COVID-19 pandemic, Public Health Emergency (PHE) provisions relaxed in-person requirements for buprenorphine inductions, expanding telehealth options for OUD treatment. This study explores patients' experiences with a digital therapeutic telehealth program offering buprenorphine for OUD.
Methods
Semi-structured qualitative interviews were conducted with 15 participants from a larger...